Chosun University Hospital Receives Top Grade in Acute Stroke and Drug Benefit Appropriateness Evaluation

[Asia Economy Honam Reporting Headquarters Reporter Yoon Jamin] Chosun University Hospital received a Grade 1 rating in the ‘Acute Stroke’ and ‘Drug Benefit’ appropriateness evaluations conducted by the Health Insurance Review and Assessment Service.

The 9th acute stroke appropriateness evaluation was conducted on patients who were admitted through the emergency room within 7 days after the onset of acute stroke symptoms among those hospitalized from October 2020 to March of last year. Chosun University Hospital earned the honor of Grade 1 for the ninth consecutive time.

Chosun University Hospital, which scored a perfect 100 points in this evaluation, received full marks in all evaluation indicators, including ▲presence of specialized personnel ▲operation of Stroke Unit ▲intravenous thrombolytic agent administration rate ▲early rehabilitation assessment rate ▲dysphagia screening test implementation rate ▲antithrombotic discharge prescription rate ▲anticoagulant discharge prescription rate ▲stroke education implementation rate, earning the highest evaluation.

Additionally, the drug benefit appropriateness evaluation conducted last year targeted outpatient prescription drugs both inside and outside the hospital from January to December, and received Grade 1 in the antibiotic prescription rate and injection prescription rate categories.

Chosun University Hospital achieved Grade 1 with a ‘Upper respiratory infection antibiotic prescription rate’ of 3.76% (overall average 35.14%) and an ‘Injection prescription rate’ of 1.54% (overall average 12.08%), recording a usage rate significantly lower than the overall average, proving that it is a hospital that practices appropriate drug prescriptions.

Hospital Director Kim Kyungjong stated, “Chosun University Hospital’s Grade 1 rating for the ninth consecutive time in the acute stroke appropriateness evaluation reconfirms that we are performing stroke treatment at the highest national level,” and expressed his ambition, saying, “We will continue to play a central role in treating stroke patients in the region through even stricter management.”

He also said, “Regarding the drug benefit appropriateness evaluation, we will strive to prevent drug misuse through continuous monitoring and ensure that antibiotics and injections are prescribed only to patients who truly need them.”

This content was produced with the assistance of AI translation services.